Olema Pharmaceuticals, Inc. (OLMA)
6.99
-0.34
(-4.64%)
USD |
NASDAQ |
Oct 30, 16:00
6.99
0.00 (0.00%)
After-Hours: 18:34
Olema Pharmaceuticals Free Cash Flow : -164.96M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -164.96M |
| March 31, 2026 | -148.72M |
| December 31, 2025 | -146.72M |
| September 30, 2025 | -134.67M |
| June 30, 2025 | -127.16M |
| March 31, 2025 | -124.84M |
| December 31, 2024 | -104.51M |
| September 30, 2024 | -96.70M |
| June 30, 2024 | -92.43M |
| March 31, 2024 | -86.98M |
| December 31, 2023 | -83.73M |
| September 30, 2023 | -85.14M |
| Date | Value |
|---|---|
| June 30, 2023 | -80.52M |
| March 31, 2023 | -84.89M |
| December 31, 2022 | -82.43M |
| September 30, 2022 | -81.85M |
| June 30, 2022 | -75.91M |
| March 31, 2022 | -58.69M |
| December 31, 2021 | -52.26M |
| September 30, 2021 | -42.03M |
| June 30, 2021 | -37.36M |
| March 31, 2021 | -29.28M |
| December 31, 2020 | -19.92M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Puma Biotechnology, Inc. | 41.16M |
| SELLAS Life Sciences Group, Inc. | -28.42M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | 0.562M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -45.90M |
| Cash from Investing (Quarterly) | 40.84M |
| Cash from Financing (Quarterly) | 1.107M |
| Free Cash Flow Per Share (Quarterly) | -0.4415 |
| Free Cash Flow to Equity (Quarterly) | -45.82M |
| Free Cash Flow to Firm (Quarterly) | -46.12M |
| Free Cash Flow Yield | -24.56% |